Catalyst

Slingshot members are tracking this event:

AMGN presents results for Repatha (evolocumab) Cardiovascular Outcomes Trial (FOURIER) at the American College of Cardiology 66th Annual Scientific Session

Source Link:
http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-eventDetails&EventId=5250216

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AMGN Community voting in process
MDCO Community voting in process
SNY Community voting in process
REGN Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Mar 17, 2017
Related Projects Image
Related Keywords Repatha, Evolocumab, American College Of Cardiology, Acc '17, Fourier, Outcomes Trial
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.